ATE470656T1 - Verfahren zur herstellung von n-acyl-2-amino-4- alkoxy-5-nitrobenzoesäuren - Google Patents

Verfahren zur herstellung von n-acyl-2-amino-4- alkoxy-5-nitrobenzoesäuren

Info

Publication number
ATE470656T1
ATE470656T1 AT03713366T AT03713366T ATE470656T1 AT E470656 T1 ATE470656 T1 AT E470656T1 AT 03713366 T AT03713366 T AT 03713366T AT 03713366 T AT03713366 T AT 03713366T AT E470656 T1 ATE470656 T1 AT E470656T1
Authority
AT
Austria
Prior art keywords
alkoxy
acyl
amino
producing
nitrobenzoic acids
Prior art date
Application number
AT03713366T
Other languages
English (en)
Inventor
Scott Duncan
Augustine OSUMA
Sylvain Daigneault
Michel Bernatchez
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of ATE470656T1 publication Critical patent/ATE470656T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
AT03713366T 2002-02-05 2003-02-04 Verfahren zur herstellung von n-acyl-2-amino-4- alkoxy-5-nitrobenzoesäuren ATE470656T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35477702P 2002-02-05 2002-02-05
PCT/US2003/003437 WO2003066575A1 (en) 2002-02-05 2003-02-04 Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids

Publications (1)

Publication Number Publication Date
ATE470656T1 true ATE470656T1 (de) 2010-06-15

Family

ID=27734420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03713366T ATE470656T1 (de) 2002-02-05 2003-02-04 Verfahren zur herstellung von n-acyl-2-amino-4- alkoxy-5-nitrobenzoesäuren

Country Status (11)

Country Link
US (2) US7227037B2 (de)
EP (1) EP1472213B1 (de)
JP (1) JP4361375B2 (de)
CN (2) CN1330627C (de)
AT (1) ATE470656T1 (de)
AU (1) AU2003217323A1 (de)
BR (1) BR0307375A (de)
CA (1) CA2475141A1 (de)
DE (1) DE60332915D1 (de)
MX (1) MXPA04007495A (de)
WO (1) WO2003066575A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1472213B1 (de) * 2002-02-05 2010-06-09 Wyeth a Corporation of the State of Delaware Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren
EA013248B1 (ru) 2002-12-20 2010-04-30 Пфайзер Продактс Инк. Производные пиримидина для лечения патологического роста клеток
US7109337B2 (en) 2002-12-20 2006-09-19 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
US7456176B2 (en) 2004-04-08 2008-11-25 Targegen, Inc. Benzotriazine inhibitors of kinases
WO2005111022A1 (en) 2004-05-14 2005-11-24 Pfizer Products Inc. Pyrimidines derivatives for the treatment of abnormal cell growth
WO2005111016A1 (en) 2004-05-14 2005-11-24 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
MXPA06011658A (es) 2004-05-14 2006-12-14 Pfizer Prod Inc Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
CN101180269A (zh) * 2005-05-25 2008-05-14 惠氏公司 制备3-氰基-喹啉的方法和由其制得的中间体
RU2007140957A (ru) * 2005-05-25 2009-06-27 Вайет (Us) Способы синтеза производных 6-алкиламинохинолинов
BRPI0610147A2 (pt) * 2005-05-25 2010-06-01 Wyeth Corp método para preparar e sintetizar 3-cianoquinolinas substituìdas e 4-amino-3-cianoquinolinas
US7528143B2 (en) 2005-11-01 2009-05-05 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
WO2012060847A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
JP6358419B2 (ja) * 2013-12-27 2018-07-18 日産化学工業株式会社 脂環式テトラカルボン酸の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2138000A1 (en) * 1994-01-03 1995-07-04 John E. Starrett, Jr. Retinoid-like compounds
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
IL151249A0 (en) * 2000-03-13 2003-04-10 American Cyanamid Co Use of cyanoquinolines for treating or inhibiting colonic polyps
EP1472213B1 (de) * 2002-02-05 2010-06-09 Wyeth a Corporation of the State of Delaware Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren

Also Published As

Publication number Publication date
CA2475141A1 (en) 2003-08-14
MXPA04007495A (es) 2004-11-10
BR0307375A (pt) 2004-12-07
CN1628093A (zh) 2005-06-15
WO2003066575A1 (en) 2003-08-14
AU2003217323A1 (en) 2003-09-02
US20050085662A1 (en) 2005-04-21
CN1330627C (zh) 2007-08-08
US7294740B2 (en) 2007-11-13
DE60332915D1 (de) 2010-07-22
EP1472213B1 (de) 2010-06-09
EP1472213A1 (de) 2004-11-03
CN101050189A (zh) 2007-10-10
JP2005517005A (ja) 2005-06-09
JP4361375B2 (ja) 2009-11-11
US20070219394A1 (en) 2007-09-20
US7227037B2 (en) 2007-06-05

Similar Documents

Publication Publication Date Title
DE60328492D1 (de) Verfahren zur erzeugung von nanoteilchen
DE60332915D1 (de) Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren
DE60138099D1 (de) Verfahren zur herstellung von substituierten octanoyl-amiden
DE60330341D1 (de) Verfahren zur herstellung von wabenstrukturen
ATE417107T1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des pts-g
DE60210697D1 (de) Verfahren zur Produktion von L-Aminosäuren mittels Bakterien der Gattung Escherichia
DE60237184D1 (de) Verfahren zur Erzeugung von Bewegungen
DE602004028370D1 (de) Verfahren zur bilderzeugung, bilderzeugungsgerät, zwischenelement, und verfahren zur modifizierung der oberfläche des zwischenelementes
DE60232605D1 (de) Verfahren zur herstellung von durchblasgetrocknetem tissueprodukt mit abdampfrückgewinnung
DE60326628D1 (de) Dorn und verfahren zur herstellung von stents
AT7109U3 (de) Verfahren zur herstellung von amlodipinmaleat
DE60105882D1 (de) Verfahren zur Herstellung von ungesättigten Aldehyden und ungesättigten Carbonsäuren
DE60304920T8 (de) Verfahren zur Herstellung von Magnesiumlegierungsprodukten
DE60324813D1 (de) Verfahren zur Herstellung von Wellenleitern
ATE331841T1 (de) Verfahren zum einbauen von weichen in geleisse sowie weiche zur durchführung dieses verfahrens
DE60038560D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin
DE50104778D1 (de) Verfahren zur herstellung von polyisobutenylphenolen
DE60026607D1 (de) Verfahren zur herstellung von perfluoroalkadienen
ATE452894T1 (de) Verfahren zur herstellung von salzen von 4-ää5- ä(cyclopropylamino)carbonylü-2- methylphenylüaminoü-5-methyl-n-propylpyrroloä2, - füä1,2,4ütriazin-6-carboxamid und damit hergestellte neue stabile formen
ATE328862T1 (de) Verfahren zur industriellen herstellung von betulinsäuren
ATE286041T1 (de) Verfahren zur industriellen herstellung von 5- amino-3-carboxymethyl-4-cyano-2- thiphencarboxydimethylester
EP1320367A4 (de) Verfahren zur herstellung von dinapsolin
DE60202034D1 (de) Verfahren zur Herstellung von Stahlrohren
DE50213632D1 (de) Verfahren zur Herstellung von registergenau gedruckten Multilayer-Aufbauten
ATE274599T1 (de) Verfahren zur enzymatischen racematspaltung von aminomethyl-aryl-cyclohexanol-derivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties